Quirindongo-Rivera Camiled, Rullán-Varela Valeria, Underill Zoe, Rivera Mayra, Ortiz-Ortiz Karen J, Martínez-Montemayor Michelle M
University of Puerto Rico Comprehensive Cancer Center, San Juan, PR.
Public Health Program, Ponce Health Science University, Ponce, PR.
J Cancer. 2022 Oct 24;13(14):3495-3502. doi: 10.7150/jca.77108. eCollection 2022.
: Breast cancer (BC) is the most diagnosed cancer and the leading cause of cancer death among women in Puerto Rico (PR). Inflammatory breast cancer (IBC) is considered the most aggressive BC subtype. This study characterized the IBC population of Hispanic women living in Puerto Rico and aimed to estimate the IBC survival rate using data from the Puerto Rico Central Cancer Registry (PRCCR). : This is a retrospective, population-based study using the PRCCR database and the Health Insurance Linkage Database (PRCCR-HILD). We analyzed data from patients that were diagnosed with IBC from January 1, 2008 to December 31, 2018. Patients were identified using the International Classification of Diseases for Oncology, 3rd edition (ICD-O-3) site codes C50.0-C50.9 and histology code 8530. Variables such as age at diagnosis, marital status, health insurance, geographic area of residence, staging variables, tumor receptor subtypes, treatment received, and overall survival (OS) were studied. Statistical analysis methods were employed to describe the population, estimate survival curves and examine the risk of dying. : The data of 51 patients were included. The mean age at diagnosis of IBC in the current study was 59 years old. A total of 62.8% of patients had no metastases at diagnosis and 64.7% were diagnosed with stage III disease. Most tumors presented with ER+/PR+/Her2- (21.6%), or a triple negative (ER-/PR-/Her2-, 15.7%) tumor concordance. The OS during the first year was 66% (90% CI: 0.54-0.76), whereas 36 months post-diagnosis was at a low 39% (90% CI: 0.27-0.59). The triple-negative subtype had the worst survival at 36 months (36% [90% CI: 0.11-0.62]). This study revealed through Cox regression analysis that women with stage IV disease and those with ER-/PR- tumor subtype have a higher risk of dying (HR 4.99; [90% CI: 2.30-10.83] and HR 4.74; [90% CI: 1.88-11.95]), respectively. : Our results suggest that the Puerto Rican IBC patient population presents unique characteristics. This is the first research to describe the patient profile and characteristics of women diagnosed with IBC in PR. This research increases awareness about this lethal disease in PR.
乳腺癌(BC)是波多黎各(PR)女性中诊断出最多的癌症,也是癌症死亡的主要原因。炎性乳腺癌(IBC)被认为是最具侵袭性的BC亚型。本研究对居住在波多黎各的西班牙裔女性IBC人群进行了特征描述,并旨在使用波多黎各中央癌症登记处(PRCCR)的数据估计IBC生存率。 :这是一项基于人群的回顾性研究,使用PRCCR数据库和健康保险关联数据库(PRCCR-HILD)。我们分析了2008年1月1日至2018年12月31日期间被诊断为IBC的患者的数据。使用国际肿瘤学疾病分类第3版(ICD-O-3)部位编码C50.0-C50.9和组织学编码8530来识别患者。研究了诸如诊断时年龄、婚姻状况、健康保险、居住地理区域、分期变量、肿瘤受体亚型、接受的治疗以及总生存期(OS)等变量。采用统计分析方法来描述人群、估计生存曲线并检查死亡风险。 :纳入了51例患者的数据。本研究中IBC诊断时的平均年龄为59岁。共有62.8%的患者在诊断时没有转移,64.7%被诊断为III期疾病。大多数肿瘤表现为ER+/PR+/Her2-(21.6%)或三阴性(ER-/PR-/Her2-,15.7%)肿瘤一致性。第一年的OS为66%(90%CI:0.54-0.76),而诊断后36个月时较低,为39%(90%CI:0.27-0.59)。三阴性亚型在36个月时生存率最差(36%[90%CI:0.11-0.62])。这项研究通过Cox回归分析显示,IV期疾病患者和ER-/PR-肿瘤亚型患者死亡风险更高(HR 4.99;[90%CI:2.30-10.83]和HR 4.74;[90%CI:1.88-11.95])。 :我们的结果表明,波多黎各IBC患者群体呈现出独特的特征。这是第一项描述PR中被诊断为IBC的女性患者概况和特征的研究。这项研究提高了PR对这种致命疾病的认识。